Streetbeat News

Stock Prices

ETHUSD

MATICUSD

The odds of Donald Trump launching a cryptocurrency before the November election have surged on Polymarket, a prediction platform, after he announced the launch date for his project, World Liberty Financial. This has led to increased betting activity, with $1.7 million wagered on the event.

Portfolio Pulse from Aniket Verma

September 13, 2024 | 7:27 am

AAPL

BAC

BRK

OXY

Warren Buffett's $13 billion investment in Occidental Petroleum (OXY) has faced challenges as the stock has dropped 29% since mid-April, influenced by a decline in crude oil prices. Despite the setback, Buffett may consider buying more shares, although a takeover is unlikely. Occidental's stock buyback plans hinge on debt reduction. Berkshire Hathaway's average purchase price is slightly above the current trading price, and Buffett holds warrants to buy more shares at a higher strike price.

Portfolio Pulse from Benzinga Neuro

September 13, 2024 | 7:14 am

BCAX

Bicara Therapeutics has priced its upsized IPO of 17.5 million common shares at $18 each. The shares will trade on the Nasdaq under the symbol 'BCAX' starting September 13, 2024, with the offering expected to close on September 16, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 7:00 am

EWQ

The Harmonised Index of Consumer Prices (HICP) in France for August increased by 0.6% month-over-month, matching the estimated growth and showing an increase from the prior month's 0.2%.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:46 am

EWQ

The Consumer Price Index (CPI) in France for August increased by 0.5% month-over-month, which is below the estimated 0.6% but higher than the previous month's 0.2%.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:46 am

GE

GEHC

GE Healthcare Technologies has priced an upsized secondary offering of 15 million common shares at $86 per share. GE HealthCare will not receive any proceeds from this offering. GE Aerospace plans to exchange these shares for its debt held by Morgan Stanley affiliates, who will then sell the shares.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:40 am

CNTA

Centessa Pharmaceuticals has announced an upsized public offering of 15,254,237 American Depositary Shares (ADS) at $14.75 per ADS, expected to raise approximately $225 million. The offering is set to close around September 16, 2024, with an option for underwriters to purchase additional shares.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 6:32 am

BABA

Alibaba Group has launched an AI-driven English version of its Taobao app in Singapore, quickly topping the App Store charts. This move is part of Alibaba's strategy to expand globally and leverage AI technology. Despite some feature improvements needed, the app's success highlights Alibaba's commitment to enhancing user experience and operational efficiency.

Portfolio Pulse from Benzinga Neuro

September 13, 2024 | 6:08 am

ZBIO

Zenas BioPharma has announced the pricing of its upsized $225 million Initial Public Offering (IPO) with 13,235,294 common shares at $17 each. The company's stock will trade on the Nasdaq under the ticker 'ZBIO' starting September 13, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 5:47 am

AAPL

Huawei's Mate XT Ultimate Design is challenging Apple's iPhone in China, but its screen replacement costs are notably high. The Mate XT's price and features are part of Huawei's strategy to compete with Apple's iPhone 16 series, which has faced criticism in China for lacking AI features.

Portfolio Pulse from Ananya Gairola

September 13, 2024 | 5:34 am